FFM

Fairmount Funds Management Portfolio holdings

AUM $772M
1-Year Est. Return 35.05%
This Quarter Est. Return
1 Year Est. Return
+35.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$237M
AUM Growth
-$42.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
22
New
Increased
Reduced
Closed

Top Buys

1
+$13.8M
2
+$8.29M
3
+$6.73M
4
MCRB icon
Seres Therapeutics
MCRB
+$1.98M
5
AXSM icon
Axsome Therapeutics
AXSM
+$1.78M

Top Sells

1
+$10.9M
2
+$5.2M
3
+$1.66M
4
GBT
Global Blood Therapeutics, Inc.
GBT
+$1.63M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$464K

Sector Composition

1 Healthcare 94.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$32.8M 13.81%
961,797
2
$27.4M 11.56%
1,405,259
+424,614
3
$17.9M 7.55%
565,890
4
$16.9M 7.14%
147,662
5
$14.2M 6%
251,598
+31,500
6
$14.2M 5.99%
1,323,181
-155,000
7
$14.2M 5.97%
51,450
+1,500
8
$13.8M 5.81%
+27,500
9
$13.7M 5.77%
1,558,975
10
$11.6M 4.9%
67,800
+7,300
11
$11.2M 4.7%
432,317
-18,000
12
$9.99M 4.21%
80,412
+5,000
13
$8.44M 3.56%
171,147
+20,714
14
$7.79M 3.29%
788,980
-526,415
15
$7.27M 3.06%
17,651
+4,800
16
$7.13M 3.01%
175,000
-40,000
17
$6.73M 2.84%
+109,333
18
$702K 0.3%
83,944
-16,056
19
$581K 0.24%
35,092
20
$526K 0.22%
+50,000
21
$154K 0.06%
+8,861
22
– –
-46,823